CA2377084A1 - Methods and compositions for engineering of attenuated vaccines - Google Patents

Info

Publication number

CA2377084A1

CA2377084A1 CA002377084A CA2377084A CA2377084A1 CA 2377084 A1 CA2377084 A1 CA 2377084A1 CA 002377084 A CA002377084 A CA 002377084A CA 2377084 A CA2377084 A CA 2377084A CA 2377084 A1 CA2377084 A1 CA 2377084A1

Authority

CA

Canada

Prior art keywords

cells

viruses

virus

attenuated

nucleic acid

Prior art date

1999-06-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 270
• 229940031567 attenuated vaccine Drugs 0.000 title claims abstract description 126
• 239000000203 mixture Substances 0.000 title claims description 43
• 241000700605 Viruses Species 0.000 claims abstract description 446
• 229960005486 vaccine Drugs 0.000 claims abstract description 225
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 200
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 175
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 175
• 230000002238 attenuated effect Effects 0.000 claims abstract description 170
• 238000012216 screening Methods 0.000 claims abstract description 116
• 230000003612 virological effect Effects 0.000 claims abstract description 59
• 230000001580 bacterial effect Effects 0.000 claims abstract description 26
• 244000045947 parasite Species 0.000 claims abstract description 23
• 210000004027 cell Anatomy 0.000 claims description 430
• 108090000623 proteins and genes Proteins 0.000 claims description 202
• 108020004414 DNA Proteins 0.000 claims description 103
• 230000006798 recombination Effects 0.000 claims description 86
• 238000005215 recombination Methods 0.000 claims description 86
• 230000001717 pathogenic effect Effects 0.000 claims description 78
• 208000015181 infectious disease Diseases 0.000 claims description 74
• 102000004169 proteins and genes Human genes 0.000 claims description 68
• 230000028993 immune response Effects 0.000 claims description 64
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 51
• 241001465754 Metazoa Species 0.000 claims description 49
• 238000000338 in vitro Methods 0.000 claims description 49
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 49
• 229920001184 polypeptide Polymers 0.000 claims description 48
• 230000014509 gene expression Effects 0.000 claims description 46
• 238000001727 in vivo Methods 0.000 claims description 46
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 45
• 201000010099 disease Diseases 0.000 claims description 44
• 238000002255 vaccination Methods 0.000 claims description 44
• 230000001976 improved effect Effects 0.000 claims description 43
• 230000035772 mutation Effects 0.000 claims description 43
• 230000002458 infectious effect Effects 0.000 claims description 40
• 238000004519 manufacturing process Methods 0.000 claims description 39
• 230000005847 immunogenicity Effects 0.000 claims description 36
• 230000002163 immunogen Effects 0.000 claims description 33
• 230000006872 improvement Effects 0.000 claims description 32
• 230000010076 replication Effects 0.000 claims description 32
• 239000012634 fragment Substances 0.000 claims description 30
• 230000001681 protective effect Effects 0.000 claims description 29
• 108020004705 Codon Proteins 0.000 claims description 27
• 230000004962 physiological condition Effects 0.000 claims description 27
• 241000894006 Bacteria Species 0.000 claims description 26
• 230000036961 partial effect Effects 0.000 claims description 26
• 108091033319 polynucleotide Proteins 0.000 claims description 25
• 102000040430 polynucleotide Human genes 0.000 claims description 25
• 239000002157 polynucleotide Substances 0.000 claims description 25
• 239000003795 chemical substances by application Substances 0.000 claims description 24
• 230000000295 complement effect Effects 0.000 claims description 24
• 241000124008 Mammalia Species 0.000 claims description 23
• 241000894007 species Species 0.000 claims description 23
• 241000282414 Homo sapiens Species 0.000 claims description 21
• 230000008774 maternal effect Effects 0.000 claims description 21
• 241000725303 Human immunodeficiency virus Species 0.000 claims description 18
• 238000012360 testing method Methods 0.000 claims description 18
• 108091060545 Nonsense suppressor Proteins 0.000 claims description 15
• 241000725643 Respiratory syncytial virus Species 0.000 claims description 15
• 230000002950 deficient Effects 0.000 claims description 15
• 230000036039 immunity Effects 0.000 claims description 15
• 230000001225 therapeutic effect Effects 0.000 claims description 15
• 108091034117 Oligonucleotide Proteins 0.000 claims description 14
• 230000007918 pathogenicity Effects 0.000 claims description 13
• 108020004511 Recombinant DNA Proteins 0.000 claims description 12
• 206010061598 Immunodeficiency Diseases 0.000 claims description 11
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 11
• 230000000694 effects Effects 0.000 claims description 11
• 239000002245 particle Substances 0.000 claims description 11
• 230000000069 prophylactic effect Effects 0.000 claims description 11
• 230000002829 reductive effect Effects 0.000 claims description 11
• 241001430294 unidentified retrovirus Species 0.000 claims description 11
• 108091026890 Coding region Proteins 0.000 claims description 10
• 241000282693 Cercopithecidae Species 0.000 claims description 9
• 241000711573 Coronaviridae Species 0.000 claims description 8
• 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims description 8
• 241000187644 Mycobacterium vaccae Species 0.000 claims description 7
• 230000006698 induction Effects 0.000 claims description 7
• 241000193738 Bacillus anthracis Species 0.000 claims description 6
• 241000710961 Semliki Forest virus Species 0.000 claims description 6
• 230000002519 immonomodulatory effect Effects 0.000 claims description 6
• 210000000987 immune system Anatomy 0.000 claims description 6
• 241001529453 unidentified herpesvirus Species 0.000 claims description 6
• 241000233866 Fungi Species 0.000 claims description 5
• 241000701806 Human papillomavirus Species 0.000 claims description 5
• 241000125945 Protoparvovirus Species 0.000 claims description 5
• 241000702670 Rotavirus Species 0.000 claims description 5
• 241000607142 Salmonella Species 0.000 claims description 5
• 230000002411 adverse Effects 0.000 claims description 5
• 238000004091 panning Methods 0.000 claims description 5
• 235000000346 sugar Nutrition 0.000 claims description 5
• 241000712461 unidentified influenza virus Species 0.000 claims description 5
• 241000710815 Dengue virus 2 Species 0.000 claims description 4
• 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 4
• 210000005260 human cell Anatomy 0.000 claims description 4
• 102000004506 Blood Proteins Human genes 0.000 claims description 3
• 108010017384 Blood Proteins Proteins 0.000 claims description 3
• 206010061041 Chlamydial infection Diseases 0.000 claims description 3
• 206010008631 Cholera Diseases 0.000 claims description 3
• 206010018693 Granuloma inguinale Diseases 0.000 claims description 3
• 241000186366 Mycobacterium bovis Species 0.000 claims description 3
• 241001505332 Polyomavirus sp. Species 0.000 claims description 3
• 241000606651 Rickettsiales Species 0.000 claims description 3
• 231100000676 disease causative agent Toxicity 0.000 claims description 3
• 230000021633 leukocyte mediated immunity Effects 0.000 claims description 3
• 230000003362 replicative effect Effects 0.000 claims description 3
• 238000003860 storage Methods 0.000 claims description 3
• 238000013519 translation Methods 0.000 claims description 3
• 201000008827 tuberculosis Diseases 0.000 claims description 3
• 208000004881 Amebiasis Diseases 0.000 claims description 2
• 206010001980 Amoebiasis Diseases 0.000 claims description 2
• 201000002909 Aspergillosis Diseases 0.000 claims description 2
• 208000036641 Aspergillus infections Diseases 0.000 claims description 2
• 208000004429 Bacillary Dysentery Diseases 0.000 claims description 2
• 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
• 206010044583 Bartonella Infections Diseases 0.000 claims description 2
• 206010005098 Blastomycosis Diseases 0.000 claims description 2
• 208000003508 Botulism Diseases 0.000 claims description 2
• 206010006500 Brucellosis Diseases 0.000 claims description 2
• 206010069748 Burkholderia pseudomallei infection Diseases 0.000 claims description 2
• 208000027312 Bursal disease Diseases 0.000 claims description 2
• 241000222122 Candida albicans Species 0.000 claims description 2
• 206010007134 Candida infections Diseases 0.000 claims description 2
• 241000242722 Cestoda Species 0.000 claims description 2
• 206010008803 Chromoblastomycosis Diseases 0.000 claims description 2
• 208000015116 Chromomycosis Diseases 0.000 claims description 2
• 241000710777 Classical swine fever virus Species 0.000 claims description 2
• 241000223205 Coccidioides immitis Species 0.000 claims description 2
• 201000007336 Cryptococcosis Diseases 0.000 claims description 2
• 241000221204 Cryptococcus neoformans Species 0.000 claims description 2
• 241000701022 Cytomegalovirus Species 0.000 claims description 2
• 206010012504 Dermatophytosis Diseases 0.000 claims description 2
• 241000588921 Enterobacteriaceae Species 0.000 claims description 2
• 241000710803 Equine arteritis virus Species 0.000 claims description 2
• 241000714201 Feline calicivirus Species 0.000 claims description 2
• 201000006353 Filariasis Diseases 0.000 claims description 2
• 241000724675 Hepatitis E virus Species 0.000 claims description 2
• 201000002563 Histoplasmosis Diseases 0.000 claims description 2
• 241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 2
• 241000701085 Human alphaherpesvirus 3 Species 0.000 claims description 2
• 241000702617 Human parvovirus B19 Species 0.000 claims description 2
• 208000004554 Leishmaniasis Diseases 0.000 claims description 2
• 206010024229 Leprosy Diseases 0.000 claims description 2
• 206010024238 Leptospirosis Diseases 0.000 claims description 2
• 241000186779 Listeria monocytogenes Species 0.000 claims description 2
• 241001460074 Microsporum distortum Species 0.000 claims description 2
• 241000041810 Mycetoma Species 0.000 claims description 2
• 241000204031 Mycoplasma Species 0.000 claims description 2
• 206010028470 Mycoplasma infections Diseases 0.000 claims description 2
• 241000244206 Nematoda Species 0.000 claims description 2
• 206010029443 Nocardia Infections Diseases 0.000 claims description 2
• 206010029444 Nocardiosis Diseases 0.000 claims description 2
• 241000709664 Picornaviridae Species 0.000 claims description 2
• 241000233872 Pneumocystis carinii Species 0.000 claims description 2
• 206010040550 Shigella infections Diseases 0.000 claims description 2
• 206010041736 Sporotrichosis Diseases 0.000 claims description 2
• 235000014897 Streptococcus lactis Nutrition 0.000 claims description 2
• 208000002474 Tinea Diseases 0.000 claims description 2
• 201000005485 Toxoplasmosis Diseases 0.000 claims description 2
• 241000242541 Trematoda Species 0.000 claims description 2
• 241000869417 Trematodes Species 0.000 claims description 2
• 206010044608 Trichiniasis Diseases 0.000 claims description 2
• 208000034784 Tularaemia Diseases 0.000 claims description 2
• 241000710772 Yellow fever virus Species 0.000 claims description 2
• 241000607734 Yersinia <bacteria> Species 0.000 claims description 2
• 206010061418 Zygomycosis Diseases 0.000 claims description 2
• 201000007691 actinomycosis Diseases 0.000 claims description 2
• 201000008680 babesiosis Diseases 0.000 claims description 2
• 206010004145 bartonellosis Diseases 0.000 claims description 2
• 201000003984 candidiasis Diseases 0.000 claims description 2
• 201000004308 chancroid Diseases 0.000 claims description 2
• 201000003486 coccidioidomycosis Diseases 0.000 claims description 2
• 230000001010 compromised effect Effects 0.000 claims description 2
• 206010014599 encephalitis Diseases 0.000 claims description 2
• 244000053095 fungal pathogen Species 0.000 claims description 2
• 201000006592 giardiasis Diseases 0.000 claims description 2
• 208000005252 hepatitis A Diseases 0.000 claims description 2
• 201000004792 malaria Diseases 0.000 claims description 2
• 201000004015 melioidosis Diseases 0.000 claims description 2
• 201000007524 mucormycosis Diseases 0.000 claims description 2
• 201000004409 schistosomiasis Diseases 0.000 claims description 2
• 201000005113 shigellosis Diseases 0.000 claims description 2
• 208000006379 syphilis Diseases 0.000 claims description 2
• 208000003982 trichinellosis Diseases 0.000 claims description 2
• 201000007588 trichinosis Diseases 0.000 claims description 2
• 201000002311 trypanosomiasis Diseases 0.000 claims description 2
• 241001148471 unidentified anaerobic bacterium Species 0.000 claims description 2
• 229940051021 yellow-fever virus Drugs 0.000 claims description 2
• 241000712891 Arenavirus Species 0.000 claims 1
• 241000304886 Bacilli Species 0.000 claims 1
• 241000186810 Erysipelothrix rhusiopathiae Species 0.000 claims 1
• 208000005176 Hepatitis C Diseases 0.000 claims 1
• 208000005331 Hepatitis D Diseases 0.000 claims 1
• 241001479210 Human astrovirus Species 0.000 claims 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 1
• 241000194035 Lactococcus lactis Species 0.000 claims 1
• 241000295644 Staphylococcaceae Species 0.000 claims 1
• 206010043376 Tetanus Diseases 0.000 claims 1
• 208000002672 hepatitis B Diseases 0.000 claims 1
• 201000010284 hepatitis E Diseases 0.000 claims 1
• 235000015097 nutrients Nutrition 0.000 claims 1
• 239000000427 antigen Substances 0.000 description 48
• 108091007433 antigens Proteins 0.000 description 48
• 102000036639 antigens Human genes 0.000 description 48
• 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 47
• 238000013459 approach Methods 0.000 description 36
• 239000002299 complementary DNA Substances 0.000 description 33
• 239000013598 vector Substances 0.000 description 33
• 244000052769 pathogen Species 0.000 description 32
• 238000011161 development Methods 0.000 description 31
• 230000018109 developmental process Effects 0.000 description 31
• 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 description 28
• 241000711549 Hepacivirus C Species 0.000 description 26
• 230000000890 antigenic effect Effects 0.000 description 24
• 230000012010 growth Effects 0.000 description 24
• 230000003053 immunization Effects 0.000 description 21
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 20
• 238000003556 assay Methods 0.000 description 20
• 238000002649 immunization Methods 0.000 description 19
• 229960004854 viral vaccine Drugs 0.000 description 19
• 206010028980 Neoplasm Diseases 0.000 description 18
• 238000002703 mutagenesis Methods 0.000 description 17
• 231100000350 mutagenesis Toxicity 0.000 description 17
• 241000701083 Bovine alphaherpesvirus 1 Species 0.000 description 16
• 206010012310 Dengue fever Diseases 0.000 description 16
• 241000699670 Mus sp. Species 0.000 description 16
• 241001467552 Mycobacterium bovis BCG Species 0.000 description 16
• 238000009472 formulation Methods 0.000 description 16
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 description 15
• 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 15
• 239000002253 acid Substances 0.000 description 14
• 238000009396 hybridization Methods 0.000 description 14
• 239000002773 nucleotide Substances 0.000 description 14
• 125000003729 nucleotide group Chemical group 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 14
• 208000001490 Dengue Diseases 0.000 description 13
• 241000711450 Infectious bronchitis virus Species 0.000 description 13
• 150000007513 acids Chemical class 0.000 description 13
• 230000008901 benefit Effects 0.000 description 13
• 238000009739 binding Methods 0.000 description 13
• 208000025729 dengue disease Diseases 0.000 description 13
• 238000006386 neutralization reaction Methods 0.000 description 13
• 239000013612 plasmid Substances 0.000 description 13
• 239000000758 substrate Substances 0.000 description 13
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 12
• 241000701931 Canine parvovirus Species 0.000 description 12
• 241000282412 Homo Species 0.000 description 12
• 241001631646 Papillomaviridae Species 0.000 description 12
• 239000000443 aerosol Substances 0.000 description 12
• 150000001413 amino acids Chemical class 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 230000027455 binding Effects 0.000 description 12
• 241000710929 Alphavirus Species 0.000 description 11
• 241000282472 Canis lupus familiaris Species 0.000 description 11
• 241000341655 Human papillomavirus type 16 Species 0.000 description 11
• 241000702626 Infectious bursal disease virus Species 0.000 description 11
• 208000003152 Yellow Fever Diseases 0.000 description 11
• 230000001965 increasing effect Effects 0.000 description 11
• 230000003389 potentiating effect Effects 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 238000011282 treatment Methods 0.000 description 11
• 241000283690 Bos taurus Species 0.000 description 10
• 102100034349 Integrase Human genes 0.000 description 10
• 210000004962 mammalian cell Anatomy 0.000 description 10
• 230000001404 mediated effect Effects 0.000 description 10
• 239000000523 sample Substances 0.000 description 10
• 238000012217 deletion Methods 0.000 description 9
• 230000037430 deletion Effects 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 230000002068 genetic effect Effects 0.000 description 9
• 239000013615 primer Substances 0.000 description 9
• 238000007423 screening assay Methods 0.000 description 9
• 238000006467 substitution reaction Methods 0.000 description 9
• 230000001018 virulence Effects 0.000 description 9
• 241000712083 Canine morbillivirus Species 0.000 description 8
• 241000588724 Escherichia coli Species 0.000 description 8
• 241000710831 Flavivirus Species 0.000 description 8
• 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 8
• 241000287828 Gallus gallus Species 0.000 description 8
• 241000712431 Influenza A virus Species 0.000 description 8
• 125000003275 alpha amino acid group Chemical group 0.000 description 8
• 238000004113 cell culture Methods 0.000 description 8
• 230000007246 mechanism Effects 0.000 description 8
• 238000002360 preparation method Methods 0.000 description 8
• 230000008569 process Effects 0.000 description 8
• 238000001890 transfection Methods 0.000 description 8
• 101710091045 Envelope protein Proteins 0.000 description 7
• 101710188315 Protein X Proteins 0.000 description 7
• 241000700618 Vaccinia virus Species 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 201000011510 cancer Diseases 0.000 description 7
• 235000013330 chicken meat Nutrition 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 230000010354 integration Effects 0.000 description 7
• 239000003550 marker Substances 0.000 description 7
• 230000003472 neutralizing effect Effects 0.000 description 7
• 102000005962 receptors Human genes 0.000 description 7
• 108020003175 receptors Proteins 0.000 description 7
• 239000003981 vehicle Substances 0.000 description 7
• 108090000288 Glycoproteins Proteins 0.000 description 6
• 102000003886 Glycoproteins Human genes 0.000 description 6
• 229930006000 Sucrose Natural products 0.000 description 6
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
• 108010067390 Viral Proteins Proteins 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 230000004077 genetic alteration Effects 0.000 description 6
• 231100000118 genetic alteration Toxicity 0.000 description 6
• 210000004392 genitalia Anatomy 0.000 description 6
• 230000001939 inductive effect Effects 0.000 description 6
• 238000011081 inoculation Methods 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 238000004806 packaging method and process Methods 0.000 description 6
• 230000007170 pathology Effects 0.000 description 6
• 238000010187 selection method Methods 0.000 description 6
• 230000035945 sensitivity Effects 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 239000005720 sucrose Substances 0.000 description 6
• 230000029812 viral genome replication Effects 0.000 description 6
• 241000271566 Aves Species 0.000 description 5
• 208000035473 Communicable disease Diseases 0.000 description 5
• 241000725619 Dengue virus Species 0.000 description 5
• 241000710829 Dengue virus group Species 0.000 description 5
• 241000282579 Pan Species 0.000 description 5
• 101710172711 Structural protein Proteins 0.000 description 5
• 241000282887 Suidae Species 0.000 description 5
• 206010046865 Vaccinia virus infection Diseases 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 230000003321 amplification Effects 0.000 description 5
• 238000010171 animal model Methods 0.000 description 5
• 210000000349 chromosome Anatomy 0.000 description 5
• 230000001186 cumulative effect Effects 0.000 description 5
• 230000034994 death Effects 0.000 description 5
• 231100000517 death Toxicity 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 239000000147 enterotoxin Substances 0.000 description 5
• 231100000655 enterotoxin Toxicity 0.000 description 5
• 239000005090 green fluorescent protein Substances 0.000 description 5
• 238000012750 in vivo screening Methods 0.000 description 5
• 238000001990 intravenous administration Methods 0.000 description 5
• 230000002147 killing effect Effects 0.000 description 5
• 230000014759 maintenance of location Effects 0.000 description 5
• 230000003211 malignant effect Effects 0.000 description 5
• 230000003505 mutagenic effect Effects 0.000 description 5
• 238000003199 nucleic acid amplification method Methods 0.000 description 5
• 229960002566 papillomavirus vaccine Drugs 0.000 description 5
• 238000000746 purification Methods 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• 238000003786 synthesis reaction Methods 0.000 description 5
• 208000007089 vaccinia Diseases 0.000 description 5
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• 208000030507 AIDS Diseases 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 102000009016 Cholera Toxin Human genes 0.000 description 4
• 108010049048 Cholera Toxin Proteins 0.000 description 4
• 108020004635 Complementary DNA Proteins 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• 208000031886 HIV Infections Diseases 0.000 description 4
• 241000712045 Morbillivirus Species 0.000 description 4
• 108091061960 Naked DNA Proteins 0.000 description 4
• 108091005461 Nucleic proteins Proteins 0.000 description 4
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 4
• 241000710960 Sindbis virus Species 0.000 description 4
• 241000272534 Struthio camelus Species 0.000 description 4
• 238000007792 addition Methods 0.000 description 4
• 239000002671 adjuvant Substances 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 230000005875 antibody response Effects 0.000 description 4
• 244000052616 bacterial pathogen Species 0.000 description 4
• 229960001212 bacterial vaccine Drugs 0.000 description 4
• 230000003247 decreasing effect Effects 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• -1 for example Proteins 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 244000144980 herd Species 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 238000000099 in vitro assay Methods 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 239000003471 mutagenic agent Substances 0.000 description 4
• 238000005457 optimization Methods 0.000 description 4
• 230000008506 pathogenesis Effects 0.000 description 4
• 229940021993 prophylactic vaccine Drugs 0.000 description 4
• 230000000241 respiratory effect Effects 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 201000010153 skin papilloma Diseases 0.000 description 4
• 235000002639 sodium chloride Nutrition 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 108010051219 Cre recombinase Proteins 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 3
• 208000004232 Enteritis Diseases 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 241000282326 Felis catus Species 0.000 description 3
• 208000007514 Herpes zoster Diseases 0.000 description 3
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 3
• 206010062016 Immunosuppression Diseases 0.000 description 3
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
• 240000007472 Leucaena leucocephala Species 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 241000150452 Orthohantavirus Species 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 208000009608 Papillomavirus Infections Diseases 0.000 description 3
• 241000702263 Reovirus sp. Species 0.000 description 3
• 208000009714 Severe Dengue Diseases 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 241000282898 Sus scrofa Species 0.000 description 3
• 108700005077 Viral Genes Proteins 0.000 description 3
• 208000000260 Warts Diseases 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 230000000840 anti-viral effect Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 230000000120 cytopathologic effect Effects 0.000 description 3
• 201000002950 dengue hemorrhagic fever Diseases 0.000 description 3
• 238000009510 drug design Methods 0.000 description 3
• 241001493065 dsRNA viruses Species 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 230000002538 fungal effect Effects 0.000 description 3
• 238000002744 homologous recombination Methods 0.000 description 3
• 230000006801 homologous recombination Effects 0.000 description 3
• 230000037451 immune surveillance Effects 0.000 description 3
• 230000001506 immunosuppresive effect Effects 0.000 description 3
• 208000037797 influenza A Diseases 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 229940031348 multivalent vaccine Drugs 0.000 description 3
• 231100000219 mutagenic Toxicity 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 238000011176 pooling Methods 0.000 description 3
• 230000007420 reactivation Effects 0.000 description 3
• 208000023504 respiratory system disease Diseases 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 230000009885 systemic effect Effects 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 244000052613 viral pathogen Species 0.000 description 3
• 210000000605 viral structure Anatomy 0.000 description 3
• 238000011179 visual inspection Methods 0.000 description 3
• 244000000057 wild-type pathogen Species 0.000 description 3
• 229940124718 AIDS vaccine Drugs 0.000 description 2
• 238000006677 Appel reaction Methods 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 241000711404 Avian avulavirus 1 Species 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 206010008342 Cervix carcinoma Diseases 0.000 description 2
• 206010068051 Chimerism Diseases 0.000 description 2
• 101710139375 Corneodesmosin Proteins 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 241000701832 Enterobacteria phage T3 Species 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 108091029865 Exogenous DNA Proteins 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• 208000000666 Fowlpox Diseases 0.000 description 2
• 208000005577 Gastroenteritis Diseases 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 108060003393 Granulin Proteins 0.000 description 2
• 206010061192 Haemorrhagic fever Diseases 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 208000019693 Lung disease Diseases 0.000 description 2
• 208000006758 Marek Disease Diseases 0.000 description 2
• 201000005505 Measles Diseases 0.000 description 2
• 101710163801 Minor capsid protein L2 Proteins 0.000 description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 101710141454 Nucleoprotein Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 102000043276 Oncogene Human genes 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 241000282577 Pan troglodytes Species 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 206010037742 Rabies Diseases 0.000 description 2
• 101150054830 S100A6 gene Proteins 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108010008038 Synthetic Vaccines Proteins 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• 108700019146 Transgenes Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• 241000700647 Variola virus Species 0.000 description 2
• 241000711975 Vesicular stomatitis virus Species 0.000 description 2
• 206010000210 abortion Diseases 0.000 description 2
• 231100000176 abortion Toxicity 0.000 description 2
• 230000006978 adaptation Effects 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 230000003466 anti-cipated effect Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• 229940065181 bacillus anthracis Drugs 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 238000009395 breeding Methods 0.000 description 2
• 230000001488 breeding effect Effects 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 238000012219 cassette mutagenesis Methods 0.000 description 2
• 201000010881 cervical cancer Diseases 0.000 description 2
• 208000019065 cervical carcinoma Diseases 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 210000003837 chick embryo Anatomy 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 235000013601 eggs Nutrition 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 101150055782 gH gene Proteins 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 238000010211 hemagglutination inhibition (HI) assay Methods 0.000 description 2
• 208000006454 hepatitis Diseases 0.000 description 2
• 231100000283 hepatitis Toxicity 0.000 description 2
• 229930195733 hydrocarbon Natural products 0.000 description 2
• 150000002430 hydrocarbons Chemical class 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 210000003292 kidney cell Anatomy 0.000 description 2
• 230000003902 lesion Effects 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 231100000707 mutagenic chemical Toxicity 0.000 description 2
• 201000009240 nasopharyngitis Diseases 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 239000012188 paraffin wax Substances 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 238000003259 recombinant expression Methods 0.000 description 2
• 229940124551 recombinant vaccine Drugs 0.000 description 2
• 238000009877 rendering Methods 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 208000017443 reproductive system disease Diseases 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 239000013605 shuttle vector Substances 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 229940083538 smallpox vaccine Drugs 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 229910001415 sodium ion Inorganic materials 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 230000035882 stress Effects 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 229940031626 subunit vaccine Drugs 0.000 description 2
• 239000002511 suppository base Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 230000005100 tissue tropism Effects 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 229940116362 tragacanth Drugs 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
• FMYBFLOWKQRBST-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]acetic acid;nickel Chemical compound [Ni].OC(=O)CN(CC(O)=O)CC(O)=O FMYBFLOWKQRBST-UHFFFAOYSA-N 0.000 description 1
• CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
• 239000013607 AAV vector Substances 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 206010003399 Arthropod bite Diseases 0.000 description 1
• 241000238421 Arthropoda Species 0.000 description 1
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
• 241001533426 Avibirnavirus Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 206010004078 Balanoposthitis Diseases 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 240000005220 Bischofia javanica Species 0.000 description 1
• 235000010893 Bischofia javanica Nutrition 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 208000013165 Bowen disease Diseases 0.000 description 1
• 208000019337 Bowen disease of the skin Diseases 0.000 description 1
• 208000011691 Burkitt lymphomas Diseases 0.000 description 1
• 241001260012 Bursa Species 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 241001493160 California encephalitis virus Species 0.000 description 1
• 241000711506 Canine coronavirus Species 0.000 description 1
• 241000700664 Capripoxvirus Species 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• 241001466804 Carnivora Species 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 208000003322 Coinfection Diseases 0.000 description 1
• 102100024206 Collectin-10 Human genes 0.000 description 1
• 101710194645 Collectin-10 Proteins 0.000 description 1
• 208000009802 Colorado tick fever Diseases 0.000 description 1
• 101710184994 Complement control protein Proteins 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 102100031673 Corneodesmosin Human genes 0.000 description 1
• 241000557626 Corvus corax Species 0.000 description 1
• 241000700626 Cowpox virus Species 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 241000709675 Coxsackievirus B3 Species 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 206010011732 Cyst Diseases 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 238000011238 DNA vaccination Methods 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 241001533413 Deltavirus Species 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 208000000655 Distemper Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 241000588877 Eikenella Species 0.000 description 1
• 244000078127 Eleusine coracana Species 0.000 description 1
• 235000013499 Eleusine coracana subsp coracana Nutrition 0.000 description 1
• 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
• 206010053025 Endemic syphilis Diseases 0.000 description 1
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
• 101000984570 Enterobacteria phage T4 Baseplate wedge protein gp53 Proteins 0.000 description 1
• 101710146739 Enterotoxin Proteins 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 101710204837 Envelope small membrane protein Proteins 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 101000997743 Escherichia phage Mu Serine recombinase gin Proteins 0.000 description 1
• 241000725579 Feline coronavirus Species 0.000 description 1
• 241000713800 Feline immunodeficiency virus Species 0.000 description 1
• 241000711475 Feline infectious peritonitis virus Species 0.000 description 1
• 241000714165 Feline leukemia virus Species 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241000701925 Feline parvovirus Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 241000606807 Glaesserella parasuis Species 0.000 description 1
• 101710114810 Glycoprotein Proteins 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 208000008913 Hantavirus Infections Diseases 0.000 description 1
• 101710154606 Hemagglutinin Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000724709 Hepatitis delta virus Species 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
• 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 1
• 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
• 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
• 101001061851 Homo sapiens V(D)J recombination-activating protein 2 Proteins 0.000 description 1
• 241000724642 Human astrovirus 1 Species 0.000 description 1
• 241001207270 Human enterovirus Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 108700005307 Human papillomavirus HPV L1 Proteins 0.000 description 1
• 241000713196 Influenza B virus Species 0.000 description 1
• 241000713297 Influenza C virus Species 0.000 description 1
• 108010061833 Integrases Proteins 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 201000005807 Japanese encephalitis Diseases 0.000 description 1
• 241000710843 Japanese encephalitis virus group Species 0.000 description 1
• 241000701646 Kappapapillomavirus 2 Species 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• 241000713102 La Crosse virus Species 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 241001492282 Lambdapapillomavirus 2 Species 0.000 description 1
• 206010023849 Laryngeal papilloma Diseases 0.000 description 1
• 206010023927 Lassa fever Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 241000700563 Leporipoxvirus Species 0.000 description 1
• 206010024971 Lower respiratory tract infections Diseases 0.000 description 1
• 241000701043 Lymphocryptovirus Species 0.000 description 1
• 208000030289 Lymphoproliferative disease Diseases 0.000 description 1
• 101710145006 Lysis protein Proteins 0.000 description 1
• 241000711828 Lyssavirus Species 0.000 description 1
• 101710141347 Major envelope glycoprotein Proteins 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 101710085938 Matrix protein Proteins 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 101710127721 Membrane protein Proteins 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000701034 Muromegalovirus Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 208000006007 Nairobi Sheep Disease Diseases 0.000 description 1
• 101710144111 Non-structural protein 3 Proteins 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• 241000702259 Orbivirus Species 0.000 description 1
• 241000713112 Orthobunyavirus Species 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 241000150218 Orthonairovirus Species 0.000 description 1
• 241000283977 Oryctolagus Species 0.000 description 1
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 241000700639 Parapoxvirus Species 0.000 description 1
• 241000606860 Pasteurella Species 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 241000713137 Phlebovirus Species 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 235000014676 Phragmites communis Nutrition 0.000 description 1
• 241000364051 Pima Species 0.000 description 1
• 241000723784 Plum pox virus Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
• 108010076039 Polyproteins Proteins 0.000 description 1
• 241000702619 Porcine parvovirus Species 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710176177 Protein A56 Proteins 0.000 description 1
• 229940096437 Protein S Drugs 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 206010037151 Psittacosis Diseases 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 101100014660 Rattus norvegicus Gimap8 gene Proteins 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 208000018569 Respiratory Tract disease Diseases 0.000 description 1
• 206010038687 Respiratory distress Diseases 0.000 description 1
• 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 1
• 241000701037 Rhadinovirus Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
• 102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
• 208000034712 Rickettsia Infections Diseases 0.000 description 1
• 241000713124 Rift Valley fever virus Species 0.000 description 1
• 208000006257 Rinderpest Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000710942 Ross River virus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 238000011579 SCID mouse model Methods 0.000 description 1
• 206010039438 Salmonella Infections Diseases 0.000 description 1
• 241001138501 Salmonella enterica Species 0.000 description 1
• 241000287231 Serinus Species 0.000 description 1
• 208000019802 Sexually transmitted disease Diseases 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 208000001203 Smallpox Diseases 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 101710167605 Spike glycoprotein Proteins 0.000 description 1
• 101710198474 Spike protein Proteins 0.000 description 1
• 241000605008 Spirillum Species 0.000 description 1
• 206010041896 St. Louis Encephalitis Diseases 0.000 description 1
• 241000710888 St. Louis encephalitis virus Species 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 241001478880 Streptobacillus moniliformis Species 0.000 description 1
• 244000057717 Streptococcus lactis Species 0.000 description 1
• 241000194021 Streptococcus suis Species 0.000 description 1
• 241000700568 Suipoxvirus Species 0.000 description 1
• 206010042971 T-cell lymphoma Diseases 0.000 description 1
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 241000710771 Tick-borne encephalitis virus Species 0.000 description 1
• 241000701067 Varicellovirus Species 0.000 description 1
• 241000870995 Variola Species 0.000 description 1
• 206010058874 Viraemia Diseases 0.000 description 1
• 108010087302 Viral Structural Proteins Proteins 0.000 description 1
• 208000028227 Viral hemorrhagic fever Diseases 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 102000018265 Virus Receptors Human genes 0.000 description 1
• 108010066342 Virus Receptors Proteins 0.000 description 1
• 241000120645 Yellow fever virus group Species 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 238000005903 acid hydrolysis reaction Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 208000012873 acute gastroenteritis Diseases 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 238000003314 affinity selection Methods 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 230000027645 antigenic variation Effects 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 208000003836 bluetongue Diseases 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 206010006060 bowenoid papulosis Diseases 0.000 description 1
• 239000000337 buffer salt Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000011148 calcium chloride Nutrition 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 229940023860 canarypox virus HIV vaccine Drugs 0.000 description 1
• 239000003560 cancer drug Substances 0.000 description 1
• 208000014058 canine distemper Diseases 0.000 description 1
• 238000001386 capillary affinity electrophoresis Methods 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 229940030156 cell vaccine Drugs 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 210000003679 cervix uteri Anatomy 0.000 description 1
• 238000009614 chemical analysis method Methods 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 229940099112 cornstarch Drugs 0.000 description 1
• 201000003740 cowpox Diseases 0.000 description 1
• 229960001681 croscarmellose sodium Drugs 0.000 description 1
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 238000009109 curative therapy Methods 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000002498 deadly effect Effects 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000009795 derivation Methods 0.000 description 1
• 230000036576 dermal application Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 230000026502 entry into host cell Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000007071 enzymatic hydrolysis Effects 0.000 description 1
• 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
• 201000004306 epidermodysplasia verruciformis Diseases 0.000 description 1
• 230000010502 episomal replication Effects 0.000 description 1
• 230000009786 epithelial differentiation Effects 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 235000020774 essential nutrients Nutrition 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 230000004907 flux Effects 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 238000011554 guinea pig model Methods 0.000 description 1
• 230000035931 haemagglutination Effects 0.000 description 1
• 208000029629 hantavirus infectious disease Diseases 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 244000052637 human pathogen Species 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000007124 immune defense Effects 0.000 description 1
• 230000008073 immune recognition Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000003125 immunofluorescent labeling Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940124589 immunosuppressive drug Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 201000005264 laryngeal carcinoma Diseases 0.000 description 1
• 201000000089 larynx squamous papilloma Diseases 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 229960001226 live attenuated influenza Drugs 0.000 description 1
• 229940124590 live attenuated vaccine Drugs 0.000 description 1
• 229960001201 live attenuated varicella Drugs 0.000 description 1
• 229940023012 live-attenuated vaccine Drugs 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 208000001581 lymphogranuloma venereum Diseases 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 230000032575 lytic viral release Effects 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 201000011475 meningoencephalitis Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 230000033607 mismatch repair Effects 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 231100000957 no side effect Toxicity 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 238000011580 nude mouse model Methods 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 230000014207 opsonization Effects 0.000 description 1
• 201000000901 ornithosis Diseases 0.000 description 1
• 229960005030 other vaccine in atc Drugs 0.000 description 1
• 210000003101 oviduct Anatomy 0.000 description 1
• 239000003002 pH adjusting agent Substances 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 230000002023 papillomaviral effect Effects 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 230000009984 peri-natal effect Effects 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 229940116317 potato starch Drugs 0.000 description 1
• 244000144977 poultry Species 0.000 description 1
• 235000013594 poultry meat Nutrition 0.000 description 1
• 244000062645 predators Species 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000001915 proofreading effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 239000001294 propane Substances 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 208000009305 pseudorabies Diseases 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• 238000011555 rabbit model Methods 0.000 description 1
• 235000002079 ragi Nutrition 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000032537 response to toxin Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• 206010039447 salmonellosis Diseases 0.000 description 1
• 238000001338 self-assembly Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000001540 sodium lactate Substances 0.000 description 1
• 229940005581 sodium lactate Drugs 0.000 description 1
• 235000011088 sodium lactate Nutrition 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 238000012421 spiking Methods 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229940031351 tetravalent vaccine Drugs 0.000 description 1
• 229940021747 therapeutic vaccine Drugs 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 241001147422 tick-borne encephalitis virus group Species 0.000 description 1
• QQJLHRRUATVHED-UHFFFAOYSA-N tramazoline Chemical compound N1CCN=C1NC1=CC=CC2=C1CCCC2 QQJLHRRUATVHED-UHFFFAOYSA-N 0.000 description 1
• 229960001262 tramazoline Drugs 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 229960002109 tuberculosis vaccine Drugs 0.000 description 1
• 241000724775 unclassified viruses Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 229940125575 vaccine candidate Drugs 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000009447 viral pathogenesis Effects 0.000 description 1
• 230000006656 viral protein synthesis Effects 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1
• 230000007810 virus-infected cell apoptotic process Effects 0.000 description 1
• 208000010484 vulvovaginitis Diseases 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 201000009482 yaws Diseases 0.000 description 1
• 229960001515 yellow fever vaccine Drugs 0.000 description 1